Mistral Ventures Inc (OTC:MILV)

CAPE CORAL, Fla., Oct. 20, 2011 /PRNewswire/ -- Mistral Ventures, Inc. (Pinksheets: MILV) announced today that is has completed the acquisition of 100% of Nature's Bioceuticals, Inc. Nature's will operate as a wholly owned subsidiary of Mistral Ventures, Inc. and is the first of many possible acquisitions in the rapidly expanding natural medicine market. Nature's Bioceuticals develops and acquires the rights to natural medicine formulas that are geared toward treating specific medical conditions. These medicines are all-natural and derived from botanicals and mineral bases.

Nature's Bioceuticals strives to provide high quality natural medicines that are as effective, if not more effective, than synthetic drugs and more importantly do not have the negative side effects usually associated with many of today's prescribed drugs.

Nature's line of Natural medicines will be either sold as prescription drugs, if applied for by the company and approved by the FDA, or sold as dietary supplements under the Dietary Supplement Health and Education Act of 1994, commonly referred to as "DSHEA."